Download Rev - Radiation and Cellular Oncology

Rev. 04/2012
CURRICULUM VITAE
Azhar M. Awan, M.D.
[email protected]
Office: Sherman Cancer Center
Sherman Hospital
1425 N. Randall Road
Elgin, IL 60123
Citizenship:
Tel:
Fax:
(224) 783-8746 or (224)783-1189
(224) 783-2842
United States
EDUCATION:

B.S. Biology,1978, Magna Cum Laude, Loyola University Chicago, Chicago, IL

M.D. 1981, Loyola University Stricth School of Medicine, Maywood, IL
Alpha Omega Alpha Medical Honor Society -
Post-graduate Training:
Internship & Residencies:

Flexible Internship, Henry Ford Hospital, Detroit, MI
1981 – 1982

Resident, Therapeutic Radiology, Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL
1982 – 1985

Chief Resident, Therapeutic Radiology, Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL
1984 – 1985
LICENSURE/CERTIFICATION:

Licensed, Physician and Surgeon, State of Illinois, #036-065175

Diplomat, National Board of Medical Examiners, I.D. #257445 (1982)

Certification, American Board of Radiology, Therapeutic Radiology (1985)
ACADEMIC APPOINTMENTS:

Instructor, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL
1982 – 1985

Instructor, Radiation & Cellular Oncology, University of Chicago Medical Center, Chicago, IL
1985 – 1986

Assistant Professor, Radiation & Cellular Oncology, University of Chicago Medical Center,
Chicago, IL
1986 – 1993

Associate Professor, Radiation & Cellular Oncology, University of Chicago Medical Center,
Chicago, IL
1993 – Present
HOSPITAL APPOINTMENTS:







Clinical Director of Radiation Oncology, Sherman Hospital, Elgin, IL
January 2010 – Present
Attending Radiation Oncologist, University of Chicago Hospital, Chicago, IL
July 1985 – Present
Associate Attending, Michael Reese Hospital, Chicago, IL
July 1985 – Present
Medical Director of Radiation Oncology, LaGrange Memorial Treatment Pavilion, LaGrange, IL
July 1988 – June 2009
Interim Director of Radiation Oncology, University of Illinois Medical Center, Chicago, IL
June 2009 – January 2010
Consultant, Weiss Memorial Hospital, Chicago, IL (resigned)
Consultant, University of Illinois Medical Center, Chicago, IL
PROFESSIONAL ASSOCIATION MEMBERSHIPS:



American Society of Therapeutic Radiology and Oncology
American Society for Clinical Oncology
American College of Radiation Oncology
WORK EXPERIENCE:






Standard Teletherapy and Brachytherapy
Experience in all major disease sites with special clinical interest in Soft Tissue Sarcomas.
3D Conformal Radiation Therapy (Beam’s Eye View/CT Based)
Prostate Brachytherapy
Endovascular Brachytherapy.
IMRT/IGRT
RECOGNITIONS/AWARDS:
1.
2.
3.
4.
5.
6.
7.
8.
9.
Chicago Metro Area Top Doctors, 2001. Selected by Castle Connolly Medical Ltd.
Chicago Metro Area Top Doctors, 2002. Selected by Castle Connolly Medical Ltd.
Chicago Metro Area Top Doctors, 2003. Selected by Castle Connolly Medical Ltd.
America’s Top Doctors, 9th Edition, January 2010. Selected by Castle Connolly Medical Ltd.
America’s Top Doctors For Cancer, 2010. Selected by Castle Connolly Medical Ltd.
America’s Top Doctors, 10th Edition, January 2011. Selected by Castle Connolly Medical Ltd.
America’s Top Doctors For Cancer, 2011. Selected by Castle Connolly Medical Ltd.
America’s Top Doctors, 11th Edition, January 2012. Selected by Castle Connolly Medical Ltd.
Chicago Magazine - Top Doctors, January 2012. Selected by Castle Connolly Medical Ltd.
PUBLICATIONS:
1)
Awan AM, Weichselbaum RR, Addington WW: Radiation Pneumonitis. In: Current Therapy of
Respiratory Disease - 2. R.R. Cherniac, Editor, pp. 183-187, 1986.
2)
Chen GTY, Kessler M, Pelizzari CA, Spelbring DR, Awan AM: Selected Advances in
Radiotherapy Treatment Planning, Varian Users Group Meeting Proceeding, Marco Island, 1986.
3)
Jacobs RH, Awan AM, Bitran JD, Hoffman PC, et al.: Prophylactic Cranial Irradiation in
Adenocarcinoma of the Lung: A Possible Role. Cancer 59:12, 2016-2019, 1987.
4)
Chen GTY, Pelizzari CA, Spelbring DA, Awan AM: Evaluation of Treatment Plans with Dose
Volume Histograms, Frontiers of Radiation Oncology, 1986, In: Treatment Planning in Radiation
Therapy of Cancer, pp. 44-55, J. Vaeth, Editor, Karger Basel, Publishers, 1987.
5)
Chen GTY, Pelizzari CA, Spelbring DA, Awan AM, Weichselbaum RR: Evaluation of Lung
Treatment Plans with Dose Volume Histograms. In: Computers in Radiotherapy. A.D. Bruinvis,
et al., (Editors), Elsevier Science Publishers, B.V., North Holland, 165-168, 1987.
6)
Spelbring D, Chen GTY, Pelizzari CA, Awan AM: Analysis of Dose Advantages of Multivane
Collimators in Therapy. In: Use of Computers in Radiation Therapy, A.D. A.D. Bruinvis, et al.,
(Editors), Elsevier Science Publishers, B.V., North Holland, 153-156, 1987.
7)
Vokes EE, Panje WR, Weichselbaum RR, Schilsky RL, Moran WJ, Awan AM, Guarnieri CM:
Concomitant Hydroxyurea, 5-Fluorouracil and Radiation Therapy for Recurrent Head and Neck
Cancer: Early Results. Otolaryngology-Head and Neck Surgery 98:295-298, 1988.
8)
Weichselbaum RR, Beckett MA, Simon MA, McCauley C, Haraf D, Awan AM, Samuels B,
Nachman J, Dritschilo A: In Vitro Radiobiological Parameters of Human Sarcoma Cell Lines. Int.
J. Rad. Onc. Bio. Phys. 15:937-942, 1988.
9)
Vokes EE, Moran WJ, Awan AM, Schilsky RL, et al.: Sequential Administration of Methotrexate,
Cisplatin, and 5-Fluorouracil in Multimodal Therapy for Locally Advanced Head and Neck Cancer.
NCI Monograph, pp. 353-356. Conference on the Interaction of Radiation Therapy and
Chemotherapy, Williamsburg, VA, 1988.
10)
Weichselbaum RR, Awan AM: Principles of Radiation Oncology. In: Lung Cancer A
Comprehensive Treatise. Jacob D. Bitran, Harvey M. Golomb, Alex S. Little, Ralph R.
Weichselbaum (Eds.). Grune & Stratton, Inc., and Harcourt Brace Jovanovich, Publishers, pp. 6170, 1988.
11)
Awan AM, Weichselbaum RR, Chen GTY: Radiation Therapy in Stage I Non-small Cell Lung
Cancer. In: Lung Cancer: A Comprehensive Treatise, Jacob D. Bitran, Harvey M. Golomb, Alex
S. Little, Ralph R. Weichselbaum (Eds.). Grune & Stratton, Inc., and Harcourt Brace Jovanovich,
Publishers, pp. 149-157, 1988.
12)
Awan AM, Weichselbaum RR: The Role of Radiation Therapy in Stage III M1 Non-small Cell
Cancer. In: Lung Cancer: A Comprehensive Treatise, Jacob D. Bitran, Harvey M. Golomb, Alex
S. Little, and Ralph R. Weichselbaum, (Eds.). Grune & Stratton Inc., and Harcourt Brace
Jovanovich, Publishers, pp. 243-253, 1988.
13)
Chen GTY, Spelbring DR, Pelizzari CA, Awan AM: A Computer Simulated Evaluation of
Multivane Collimator Beam Delivery Systems in Irradiation of Lung Tumors. Varian Users Group
Meeting Proceedings, pp. 48-50, 1988.
14)
Vokes EE, Weichselbaum RR, Moran WJ, Awan AM, Tybor AG, Goldman ME, Schilsky RL,
Bitran JD, Barker CM, Scher N, Panje WR: A Randomized Study Comparing Two Regimens of
Induction Chemotherapy for Locally Advanced Head and Neck Cancer. Neoadjuvant
Chemotherapy, Ed. Jacquillat CL, Weil M, D. Khayat Colloque INSERM/John Libbey Eurotext
Ltd., Vol. 169, pp. 309-313, 1988.
15)
Awan AM, Vokes EE, Weichselbaum RR: Advances in Radiation Oncology in the Treatment of
Head and Neck Tumors. In: Advances in Otolaryngology-Head & Neck Surgery, Volume III.
Yearbook Med. Publ., Inc., Myers, E.N. (Ed.) pp.257-288, 1989.
16)
Hallahan DE, Michel AG, Awan AM, Halpern HJ, Desser R, Bitran J, Recant W, Wyman B,
Spelbring DR, Weichselbaum RR: Breast Conserving Surgery and Definitive Irradiation for Early
Stage Breast Cancer. Int. J. Radiat. Onc. Bio. Phys. 17:1211-1216, 1989.
17)
Vokes EE, Panje WR, Schilsky RL, Mick R, Awan AM, Moran WJ, Goldman MD, Tybor AG,
Weichselbaum RR: Hydroxyurea, Fluorouracil, and Concomitant Radiotherapy in Poor-Prognosis
Head and Neck Cancer: A Phase I-II Study. J. Clin. Oncol. 7:761-768, 1989.
18)
Weichselbaum RR, Beckett MA, Vijayakumar S, Simon MA, Awan AM, Nachman J, Panje WR,
Goldman ME, Tybor AG, Moran WJ, Vokes EE, Ahmed-Swan S, and Farhangi EA:
Radiobiological Characterization of Head and Neck and Sarcoma Cells Derived from Patients Prior
to Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 19:313-319, 1990.
19)
Awan AM, and Weichselbaum RR: Palliative Radiotherapy; Non-Small Cell Lung Cancer. In:
Hematol. Clin. North Am. #4, Bitran et al. (Eds.) pp. 1169-1181, 1990.
20)
Farah R, Chodak GW, Vogelzang NJ, Awan AM, Quiet CA, Moormeier J, Schoenberg H, and
Weichselbaum RR: Curative Radiotherapy Following Chemotherapy for Invasive Bladder
Carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 20:413-417, 1991.
21)
Awan AM, Vokes EE, and Weichselbaum RR: Recent Advances in Radiation Therapy for Head
and Neck Cancer. Hematol. Clin. North Am. 5:635-655, 1991.
22)
Vokes EE, Awan AM, and Weichselbaum RR: Radiotherapy with Concomitant Chemotherapy for
Head and Neck Cancer. Hematol. Clin. North Am. 5:753-767, 1991.
23)
Vijayakumar S, Low N, Chen GTY, Myrianthopoulos LC, Culbert H, Chiru P, Spelbring D, Awan
AM, Rosenberg I, Halpern H, and Weichselbaum RR: Beam's Eye View Based-Photon
Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 21:1575-1588, 1991.
Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, and Awan AM: Racial
Differences in Prostate Specific Antigen Levels in Patients with Local-Regional Prostate Cancers.
Cancer Epidemiology, Biomarkers & Prevention. 1:541-545, 1992.
24)
25)
Vijayakumar S, Awan AM, Karrison T, Culbert H, Chan S, Kolker J, Low N, Halpern H, Rubin S,
Chen GTY: Acute Toxicity During External Beam Radiotherapy for Localized Prostate Cancer:
Comparison of Different Techniques. Int. J. Radiat. Oncol. Biol. Phys. 25:359-371, 1993.
26)
Vogelzang NJ, Moormeier JA, Awan AM, et al.: Methotrexate, Vinblastine, Doxorubicin and
Cisplatin Followed by Radiotherapy or Surgery for Muscle Invasive Bladder Cancer: The
University of Chicago Experience. J. Urol. 149:753-757, 1993.
27)
Vijayakumar S, Roach M, Wara W, Chan SK, Ewing C, Rubin S, Sutton H, Halpern H, Awan AM,
Houghton A, et al.: Effect of Subcutaneous Recombinant Human Erythropoietin in Cancer
Patients Receiving Radiotherapy: Preliminary Results of a Randomized, Open Labelled, Phase II
Trial. Int. J. Radiat. Oncol. Biol. Phys. 26:721-729, 1993.
28)
Culbert HV, Vijayakumar S, Awan AM, Borger F: A Hanging Lens Block for Orbital
Radiotherapy Using a Single Anterior Electron Beam. Acta Oncologica (Submitted).
29)
Vijayakumar S, Karrison T, Quadri SF, Chan SK, Haraf D, Pandya K, Houghton A, Rubin S,
Kalokhe, Halpern H, Muller-Runkle R, Sutton H, Awan A, Weichselbaum RR: Localized Prostate
Cancer: Use of Serial Prostate-Specific Antigen Measurements During Radiation Therapy - An
Update. Onkologie 17:578-585, 1994.
30)
Mundt AJ, Awan AM, Sibley GS, Simon M, Rubin SJ, Samuels B, Wong W, Beckett M,
Vijayakumar S, Weichselbaum RR: Conservative Surgery and Adjuvant Radiation Therapy in the
Management of Adult Soft Tissue Sarcoma. Clinical and Radiobiological Results. Accepted for
publication in Int. J. Radiat. Oncol. Biol. Phys. 32:977-985, 1995.
31)
Yang FE, Vaida F, Ignacio L, Awan AM, Culbert H, Nautiyal J, Kolker J, Sutton H, Halpern HJ,
Weichselbaum RR, Chen CTY, Vijayakumar S: Acute Toxicity in Radiotherapy of Prostate
Cancer: Results of a Randomized Study with and without Beam’s-Eye-View Three-Dimensional
Conformal Therapy. Radiation Oncology Investigations 4:231-238, 1996.
32)
Mantzavrakos CA, Song P, Farhangi E, Nautiyal J, Awan AM, Ignacio L, Weichselbaum R,
Vijayakumar S: Potency Probability Following Conformal Megavoltage Radiotherapy Using
Conventional Doses for Localized Prostate Cancer. Int. J. Rad. Oncol. Biol. Phys. 37:551-557,
1997.
33)
Getty PJ, Awan AM, Peabody TD: Management of Metastatic Disease to the Distal Femur. In:
Management of Metastatic Disease to the Musculoskeletal System. (Book Chapter, submitted
1998.)
34)
Jani AB, Chen M-H, Vaida F, Ignacio L, Awan AM, Weichselbaum RR, Vijayakumar S: PSABased Outcome Analysis Following Radiation Therapy for Prostate Cancer: A New Definition of
Biochemical Failure after Intervention. Urology 54 (4), 1999
Mantz CA, Nautiyal J, Awan A, Kopnick M, Ray P, Kandel G, Niederberger C, Ignacio L, Dawson
E, Fields R, Weichselbaum RR, Vijayakumar S: Potency Preservation Following Conformal
Radiotherapy for Localized Prostate Cancer: Impact of Neoadjuvant Androgen Blockade,
Treatment Technique and Patient-Related Factors. The Cancer Journal Vol. 5, No. 4 July/August
1999.
35)
36)
Chung TDK, Park II, Ignacio L, Catchatourian R, Kopnick M, Davison E, Conrad G, Awan AM,
Crawford D and Vijayakumar S: Television and News Print Media are Effective in Educating
Potential Participants in a Prostate Cancer Chemoprevention Trial. Int. J Cancer: 90, 302-304, 2000
37)
Connel PP, Ignacio L, Haraf D, Awan AM, Halpern H, Abdalla I, Nautiyal J, Jani AB,
Weichselbaum RR, Vijayakumar S: Equivalent Racial Outcome After Conformal Radiotherapy for
Prostate Cancer: A Single Departmental Experience. J Clin Oncology, Vol. 19, No. 1, 54-61, 2001.
38)
Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, Roach III M, Brachman D, Kalokhe U,
Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S: Changing Face
and Different Countenances of Prostate Cancer: Racial and Geographic Differences in Prostatespecific Antigen (PSA), Stage, and Grade Trends in the PSA Era. Int. J. Cancer (Radiat. Oncol.
Invest): 96, 363-371, (2001)
ABSTRACTS:
1)
Vokes EE, Moran WJ, Awan AM, Schilsky RL, et al.: Multimodality Therapy for Locally
Advanced Head and Neck Cancer. In: Proceedings of American Society for Clinical Oncology,
1986.
2)
Jacobs R, Awan AM, Bitran J, Hoffman PC, et al.: The Role for Prophylactic Cranial Irradiation in
Patients with Adenocarcinoma of the Lung. In: Proceedings of American Society for Clinical
Oncology, 1986.
3)
Vokes EE, Moran WJ, Awan AM, Schilsky RL, Goldman M, Tybor A, Weichselbaum R, Panje
WR: Neoadjuvant and Adjuvant Methotrexate, Cisplatin, and 5-FU in Multimodality Therapy of
Head and Neck Cancer. Submitted to the 5th International Conference on the Adjuvant Therapy of
Cancer, 1987.
4)
Awan AM, Spelbring DR, Chen GTY: Analysis of Serial Lung CT Scans for Therapy Efficacy
Evaluation. Proceedings of the 73rd Scientific Assembly and Annual Meeting of the RSNA, pp.
94, 1987.
5)
Chen GTY, Pelizzari CA, Spelbring DR, Halpern H, Awan AM, Weichselbaum RR:
Multimodality Image Correlation for Radiotherapy Treatment Planning of the Brain. Proceedings
of the 73rd Scientific Assembly and Annual Meeting of the RSNA, pp. 95, 1987.
6)
Vogelzang NJ, Chodak GW, Awan AM, Ruane M, Straus TH, Schoenberg HW: Neoadjuvant
Chemotherapy for Locally Invasive Transitional Cell Carcinoma of the Bladder (TCCB). Presented
at the American Association of Cancer Research, 1988.
7)
Vokes EE, Weichselbaum RR, Awan AM, Moran WJ, Tybor AG, Goldman ME, Schilsky RL,
Bitran JD, Barker CM, Scher N, Panje WR: A Randomized Study Comparing Two Regimens of
Induction Chemotherapy (IND CT) for Locally Advanced Head and Neck Cancer (HNC).
Submitted to 2nd International Congress on Neoadjuvant Chemotherapy, 1988.
8)
Vokes EE, Panje W, Schilsky R, Moran W, Awan AM, Sutton HG, Guarnieri C, Whaling S,
Weichselbaum RR: A Phase I Study of Concomitant Hydroxyurea (HU), 5-Fluorouracil (5-FU)
and Radiation Therapy (XRT) in Poor Prognosis Head and Neck Cancer (HNC). Submitted to
ASCO, 1988.
9)
Vokes EE, Moran WJ, Weichselbaum RR, Tybor AG, Goldman ME, Kozloff M, Swartz C, Scher
N, Awan AM, Panje WR: Randomized Comparison of Two Induction Chemotherapy Regimens
for Locally Advanced Head and Neck Cancer. Submitted to American Association of Cancer
Research, 1988.
10)
Vokes EE, Panje WR, Schilsky RL, Moran WJ, Awan AM, Goldman ME, Tybor AG, Guarnieri
CM, Whaling SM, Weichselbaum RR: Concomitant 5-Fluorouracil (5-FU), Hydroxyurea (HU)
and Radiotherapy (XRT): Definition of Dose and Efficacy in Advanced and Recurrent Head and
Neck Cancer (HNC). Second International Conference on Head and Neck Cancer, No. 55, p. 61,
1988.
11)
Vokes EE, Moran WJ, Weichselbaum RR, Goldman ME, Tybor AG, Awan AM, Guarnieri CM,
Whaling SM, Scher N, Panje WR: Neoadjuvant and Adjuvant Cisplatin, 5-FU, Plus Methotrexate
for Locoregionally Advanced Head and Neck Cancer (HNC). Second International Conference on
Head and Neck Cancer, No. 387, p. 144, 1988.
12)
Hallahan DE, Michel AG, Awan AM, Halpern HJ, Desser R, Bitran J, Recant W, Wyman B,
Spelbring D, Weichselbaum RR: Patterns of Failure in Pathological Stage I and II Diffuse
Histiocytic Lymphoma Treated with Radiotherapy Alone. ASTRO Ann. Mtg., 1988.
13)
Farah R, Awan AM, Quiet C, Chodak G, Vogelzang N, Weichselbaum RR: Combined Modality
Therapy for Muscle Invading Bladder Cancer: A Bladder-Sparing Treatment. Proc. of the Amer.
Radium Soci., p. 6, 1989.
14)
Farah R, Awan AM, Williams S, Golomb H, Bitran J, Weichselbaum RR: High Dose
Chemotherapy with Autologous Stem Cell Reinfusion and Radiotherapy in Refractory and
Relapsed Hodgkin's Disease. Proc. of the Amer. Radium Soci., p. 11, 1989.
15)
Culbert H, Vijayakumar S, Awan AM, Low N, Chen GTY: Acute Toxicity and Volumetric
Comparison of Different Techniques in Patients Treated with Radical Radiotherapy in Prostate
Cancer. Proceedings of the American Society for Therapeutic Radiology and Oncology 33rd
Annual Meeting, 21, (S1):230, Washington, DC, November 4-8, 1991.
16)
Vijayakumar S, Wara WM, Roach M, Awan AM, Weichselbaum RR: The Effects of
Subcutaneous (SC) Recombinant Human Erythropoietin (EPO) in Cancer (Ca) Patients (pts)
Receiving Radiotherapy (RT). Proceedings of the American Society for Therapeutic Radiology and
Oncology 34th Annual Meeting, 24(S1):272, San Diego, CA, November 9-13, 1992.
17)
Vijayakumar S, Karrison T, Chan S, Awan AM, Quadri S: An Analysis of Factors Affecting
Prostate Specific Antigen (PSA) Levels in Non-metastatic Prostate Cancer (PC). The Society of
Nuclear Medicine Central Chapter Meeting, Chicago, IL, March 12-15, 1992.
18)
Sweeney PJ, Vijayakumar S, Barnard J, Dong L, Awan AM, Weichselbaum RR: Prognostic
Significance of Stage, Grade, Race, Pre-Treatment PSA, PSA Half-life, Prostate Volume and PSA
Density in Patients Undergoing External Beam Radiotherapy for Localized Prostate Cancer: A
Logistic Regression Analysis. Proceedings of the 35th Annual ASTRO Meeting, New Orleans
Convention Center, New Orleans, LA, Vol. 27, pp. 283-284, October 11-15, 1993.
19)
Chen L, Powers C, Awan AM, Halpern H, Krishnasamy S, Mundt A, Heimann R: Significance of
Family History in Early Stage Breast Cancer Treated with Breast Conservation Therapy. (ASTRO
Ann. Mtg., 1994.)
20)
Chung TDK, Park II, Ignacio L, Catchatourian R, Kopnick M, Davison E, Conrad G, Awan AM,
Vijayakumar S: Television and News Print Media are Effective in Educating Potential Participants
in a Prostate Cancer Chemoprevention Trial. (Publication, submitted 1998.)
21)
Brockstein B, Peabody T, Samuels B, Mundt A, Awan AM, Simon M: Preoperative Chemotherapy
and Radiotherapy (RT) for Poor Prognosis Extremity Soft Tissue Sarcomas. (Abstract, submitted
to CTOS, 1998).
22)
B. Aydogan, G. O. Kavak, M. Koshy, N. Ozturk, M. Yeginer, B. Smith, P. Patel, Awan AM, M.
Surucu, R. R. Weichselbaum, D.Rondelli: Initial Clinical Experience With Linac-based
Intensity Modulated Total Marrow Irradiation (im-tmi). (POSTER # 1091 presented at ASTRO
Oct.2011)